Novo Nordisk launches new insulin device

NEW YORK — Novo Nordisk has launched a new insulin pen designed for children with diabetes.



The new NovoPen Echo is the first and only prefilled pen device in the United States that allows for half-unit dosing in combination with a memory function, the company said.



This function not only allows for finer dosing adjustment based on the needs of the child, but will also allow parents to see how much insulin their child has taken and how much time has elapsed since the last dose was administered.